Back

Sidley Continues Strategic Growth of Global Life Sciences Practice With Addition of Corporate Lawyers Deepa Rich and Sam Zucker

Sidley announced that Deepa Rich and Sam Zucker have joined Sidley’s office in Palo Alto as partners in the Global Life Sciences practice. They join from Goodwin Procter LLP, where they were partners in the firm’s Silicon Valley office. Both are returning to Sidley, where they practiced before joining Goodwin.

Deepa Rich and Sam Zucker advise emerging and high-growth life sciences and healthcare companies globally, including those in the biotechnology, medical device, diagnostics, and digital health sectors, as well as investors and investment banks, on a broad range of corporate and strategic transactions. Their extensive financing experience spans startup, venture capital, and private equity financings, as well as public company securities offerings, including initial public offerings, follow-on offerings, confidentially marketed public offerings, registered direct offerings, and private investments in public equity. They also represent underwriters in these transactions. They represent buyers and sellers in mergers and acquisitions, including joint ventures, strategic alliances, collaborations, and divestitures.

In addition, Deepa Rich and Sam Zucker advise management teams and boards of directors on corporate governance, public company reporting, regulatory matters involving the U.S. Securities and Exchange Commission (SEC) and Nasdaq, corporate development, and capital markets strategies.

“The continued expansion of our Global Life Sciences practice remains a significant strategic priority for Sidley,” said Sharon Flanagan, leader of Sidley’s Global Life Sciences practice and a member of the firm’s Management Committee and Executive Committee. “Deepa and Sam’s return builds on our significant investments in the key emerging life sciences centers in Northern California, San Diego, and Boston. Their experience advising boards, management teams, and their advisors and investors on the most significant capital raising transactions, from venture capital to initial public offerings to complex capital markets transactions, as well as on strategic collaborations and mergers and acquisitions, including arrangements that provide financial and operational support as new drug candidates advance through clinical trials, adds further depth to our life sciences transactional platform.”

“Deepa and Sam bring valuable experience advising life sciences companies, investment banks, and investors,” said Martin Wellington, co-leader of Sidley’s Emerging Companies and Venture Capital practice, managing partner of the Palo Alto office, and a member of the firm’s Executive Committee. “I’m excited for the opportunity to work with Deepa and Sam again, and their return further strengthens our emerging companies and venture capital platform and expands our ability to support innovative companies as they raise capital, pursue strategic transactions, and navigate their next stages of growth.”

LEGAL DESIRE NEWSLETTER

Where the legal industry reads first.

Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.

No spam. Unsubscribe anytime.

From Legal Desire

Is your firm the one being cited, or the one being skipped?

We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.

Lawyers and firms: get featured on Legal Desire

Share your deals, lateral moves, firm news and insights with 1M+ monthly readers: founders, law firm partners, general counsel and practising lawyers across the US, UK, EU and GCC.

Get featuredSubmit a press release
Cynthia Lydia Marbaniang
Associate & Staff Writer